er logo points to home page Home page Search Glossary Search Links Database Sitemap Contact Expert Reviews in Molecular Medicine
          Register interest

Expert Reviews in Molecular Medicine: http://www.expertreviews.org/
DOI: 10.1017/S1462399405009981; 18 October 2005
Oliver Brand, Stephen Gough and Joanne Heward (2005) HLA, CTLA-4 and PTPN22: the shared genetic master-key to autoimmunity?

Expert Rev. Mol. Med. Vol. 7, Issue 23, DOI: 10.1017/S1462399405009981


HLA, CTLA-4 and PTPN22: the shared genetic master-key to autoimmunity?

Oliver Brand, Stephen Gough and Joanne Heward

Author contact details

Several genetic loci appear to be involved in susceptibility to autoimmune disease. Some loci are disease specific, whereas others appear to exert a general effect on the autoimmune disease process. Despite a large number of studies of many different diseases, consistent associations with multiple autoimmune disorders have been restricted to three gene regions: the human leukocyte antigen (HLA) class II region on chromosome 6p21, the gene encoding cytotoxic T lymphocyte-associated 4 (CTLA-4) on chromosome 2q33, and the PTPN22 gene encoding lymphoid tyrosine phosphatase (LYP) on chromosome 1p13. Each of these loci is likely to encode molecules that are crucial in the immune cascade and are actively involved in T-cell activation. Moreover, gene polymorphisms that affect function might contribute to the triggering of autoimmune disease by as-yet-unknown mechanisms. This review summarises recent developments and current understanding of the way in which molecules encoded by these susceptibility loci contribute to T-cell activation, and hypothesises how aberrant function of these molecules might trigger autoimmunity.

Full text online (purchase or subscribe through Cambridge Journals Online)

Free features associated with this article

Figure 1. A schematic diagram showing the major genes within the HLA class II region.
Web, PDF
Figure 2. Proposed mechanisms by which CTLA-4 inhibits T-cell activation.
Web, PDF
Figure 3. Proposed mechanisms by which LYP affects T-cell activation.
Web, PDF
Figure 4. Proposed mechanism by which CTLA-4 might use LYP/Grb2 to inhibit T-cell activation.
Web, PDF
Table 1. HLA class II haplotype associations with autoimmune disease.
Web, PDF

| home | search | glossary | links | sitemap | contact |

Expert Reviews in Molecular Medicine © Cambridge University Press ISSN 1462-3994 (Disclaimer and copyright)
Editorial Office: Centre for Applied Research in Educational Technologies (CARET), 1st Floor, 16 Mill Lane, Cambridge, CB2 1SB, UK. Tel: +44 (0)1223 765 375; Fax: +44(0)1223 765 505; E-mail: ermm@caret.cam.ac.uk